|
|
||||||||
Nobel Institute for Neurophysiology, Department of Neuroscience, Karolinska institutet, SE 17177 Stockholm, Sweden
Submitted 8 March 2004; accepted in final form 7 June 2004
The spinal network coordinating locomotion is comprised of a core of glutamate and glycine interneurons. This network is modulated by several transmitter systems including spinal GABA interneurons. The purpose of this study is to explore the contribution of GABAergic neurons to the regulation of locomotor burst frequency in the lamprey model. Using gabazine, a competitive GABAA antagonist more specific than bicuculline, the goal was to provide a detailed analysis of the influence of an endogenous activation of GABAA receptors on fictive locomotion, as well as their possible interaction with GABAB and involvement of GABAC receptors. During N-methyl-D-aspartate (NMDA)-induced fictive locomotion (ventral root recordings in the isolated spinal cord), gabazine (0.1100 µM) significantly increased the burst rate up to twofold, without changes in regularity or "burst quality." Gabazine had a proportionately greater effect at higher initial burst rates. Picrotoxin (17.5 µM), a less selective GABAA antagonist, also produced a pronounced increase in frequency, but at higher concentrations, the rhythm deteriorated, likely due to the unspecific effects on glycine receptors. The selective GABAB antagonist CGP55845
This article has been cited by other articles:
50%, presumably due to presynaptic and soma-dendritic effects documented previously. It is not required for burst generation, but acts as a powerful modulator.
Address for reprint requests and other correspondence: S. Grillner, Nobel Inst. for Neurophysiology, Dept. of Neuroscience, Karolinska Institutet, SE 17177 Stockholm, Sweden (E-mail: Sten.Grillner{at}neuro.ki.se).
![]()
![]()

![]()
![]()
![]()
O. Ibanez-Sandoval, L. Carrillo-Reid, E. Galarraga, D. Tapia, E. Mendoza, J. C. Gomora, J. Aceves, and J. Bargas
Bursting in Substantia Nigra Pars Reticulata Neurons In Vitro: Possible Relevance for Parkinson Disease
J Neurophysiol,
October 1, 2007;
98(4):
2311 - 2323.
[Abstract]
[Full Text]
[PDF]
![]()
![]()
![]()

![]()
![]()
![]()
N. A. Tsvyetlynska, R. H. Hill, and S. Grillner
Role of AMPA Receptor Desensitization and the Side Effects of a DMSO Vehicle on Reticulospinal EPSPs and Locomotor Activity
J Neurophysiol,
December 1, 2005;
94(6):
3951 - 3960.
[Abstract]
[Full Text]
[PDF]
![]()
HOME
HELP
FEEDBACK
SUBSCRIPTIONS
ARCHIVE
SEARCH
TABLE OF CONTENTS
Copyright © 2004 by the The American Physiological Society.
Visit Other APS Journals Online